LCG
SGRY icon

Lisanti Capital Growth’s Surgery Partners SGRY Stock Holding History

Lisanti Capital Growth’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-224,375
Closed -$10.1M – 167
2023
Q2 		$10.1M Buy
224,375
+132,545
+144% +$5.06M 1.4% 16
2023
Q1 		$3.17M Buy
91,830
+55,130
+150% +$1.79M 0.44% 89
2022
Q4 		$1.02M Buy
+36,700
New +$972K 0.14% 119
2021
Q4 		– Sell
-29,255
Closed -$1.24M – 142
2021
Q3 		$1.24M Sell
29,255
-230,830
-89% -$11.8M 0.18% 125
2021
Q2 		$17.3M Buy
260,085
+71,870
+38% +$3.9M 2.15% 3
2021
Q1 		$8.33M Buy
+188,215
New +$6.99M 1.07% 34

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lisanti Capital Growth's SGRY Position: Q3 2023 in Review

Lisanti Capital Growth sold out of Surgery Partners (SGRY) in Q3 2023, closing a stake of 224,375 shares — an estimated $10.1M sold.

Lisanti Capital Growth first reported a position in SGRY in Q1 2021 and held it in 6 quarters. The position peaked at $17.3M in Q2 2021. 164 funds tracked by Wall St. Rank hold SGRY as of Q3 2023.

  • Lisanti Capital Growth reported no remaining Surgery Partners position as of Q3 2023 after selling out during the quarter.
  • Lisanti Capital Growth sold 224,375 Surgery Partners shares in Q3 2023, an estimated $10.1M.
  • Lisanti Capital Growth first reported a position in Surgery Partners in Q1 2021 and held it in 6 quarters.
  • Lisanti Capital Growth's Surgery Partners position peaked at $17.3M in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2023.

Based on Lisanti Capital Growth's 13F filing for Q3 2023, filed 3 Nov 2023.